XML 31 R15.htm IDEA: XBRL DOCUMENT
v3.8.0.1

SHARE-BASED PAYMENTS | 3 Months Ended
--- | ---
Mar. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Share-Based Payments | SHARE-BASED PAYMENTS The Company, under the 2015 Omnibus Equity Incentive Compensation Plan (the “Compensation Plan”), maintains a stock incentive plan for directors, executives, eligible employees and consultants. Stock incentive awards include employee stock options and restricted stock units (“RSUs”). The Company issues new shares of common stock to satisfy exercises and vesting under all of its stock incentive awards. At March 31, 2018, a total of 7,597,727 Common Shares were authorized for stock incentive plan awards. Employee Stock Options The Company, under the Compensation Plan may grant options to directors, executives, employees and consultants to purchase Common Shares of the Company. The exercise price of the options is set as the higher of the Company’s closing share price on the day before the grant date or the five-day volume weighted average price. Stock options granted under the Compensation Plan generally vest over a period of two years or more and are generally exercisable over a period of five years from the grant date not to exceed 10 years. The value of each option award is estimated at the grant date using the Black-Scholes Option Valuation Model. There were 0.42 million options granted in the three months ended March 31, 2018 (three months ended March 31, 2017 – 0.73 million options). At March 31, 2018, there were 2.36 million options outstanding with 1.78 million options exercisable, at a weighted average exercise price of $3.76 and $4.30 respectively, with a weighted average remaining contractual life of 3.73 years. The aggregate intrinsic value of the fully vested options was $0.01 million. The fair value of the options granted under the Compensation Plan for the three months ended March 31, 2018 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted-average assumptions:
Risk-free interest rate | 2.840 |
Expected life | 5.0 years | *
Expected volatility | 59.0 |
Expected dividend yield | 0.00% |
Weighted-average expected life of option | 5.00 |
Weighted-average grant date fair value | $0.96 |
* | Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the options.
The summary of the Company’s stock options at March 31, 2018 and December 31, 2017, and the changes for the fiscal periods ending on those dates is presented below:
| Range of Exercise Prices $ |  | Weighted Average Exercise Price $ |  | Number of Options
Balance, December 31, 2016 | 2.12 - 15.61 |  |  | 5.69 |  |  | 2,045,143 |
Granted | 1.77 - 2.35 |  |  | 2.34 |  |  | 738,893 |
Exercised | — |  |  | — |  |  | — |
Forfeited | 2.12 - 11.94 |  |  | 2.93 |  |  | (316,289 | )
Expired | 4.48 - 12.55 |  |  | 8.42 |  |  | (438,900 | )
Balance, December 31, 2017 | 1.77 - 15.61 |  |  | 4.48 |  |  | 2,028,847 |
Granted | 1.70 |  |  | 1.70 |  |  | 422,956 |
Exercised | — |  |  | — |  |  | — |
Forfeited | 2.12 - 7.02 |  |  | 3.76 |  |  | (18,849 | )
Expired | 10.36 |  |  | 10.36 |  |  | (77,264 | )
Balance, March 31, 2018 | 1.70 - 15.61 |  |  | 3.76 |  |  | 2,355,690 |
A summary of the status and activity of non-vested stock options for the three months ended March 31, 2018 is as follows:
| Number of shares |  | Weighted Average Grant- Date Fair Value
Non-vested December 31, 2017 | 365,180 |  |  | $ | 1.20 |
Granted | 422,956 |  |  | 0.91 |
Vested | (215,315 | ) |  | 0.92 |
Forfeited | (1,644 | ) |  | 1.30 |
Non-vested March 31, 2018 | 571,178 |  |  | $ | 1.09 |
Restricted Stock Units The Company grants RSUs to executives and eligible employees. Awards are determined as a target percentage of base salary and generally vest over periods of three years. Prior to vesting, holders of restricted stock units do not have the right to vote the underlying shares. The RSUs are subject to forfeiture risk and other restrictions. Upon vesting, the employee is entitled to receive one share of the Company’s common stock for each RSU for no additional payment. During the three months ended March 31, 2018, the Company's Board of Directors approved the issuance of 1.19 million RSUs under the Compensation Plan (March 31, 2017 -1.13 million). A summary of the status and activity of non-vested RSUs at March 31, 2018 is as follows:
| RSU
| Number of shares |  | Weighted Average Grant- Date Fair Value
Non-vested December 31, 2017 | 1,909,477 |  |  | $ | 2.17 |
Granted | 1,191,132 |  |  | 1.70 |
Vested | (1,486,126 | ) |  | 2.24 |
Forfeited | — |  |  | — |
Non-vested March 31, 2018 | 1,614,483 |  |  | $ | 1.99 |
The total intrinsic value and fair value of RSUs that vested and were settled for equity in the three months ended March 31, 2018 was $2.41 million (March 31, 2017 – $1.64 million). The share-based compensation recorded during the three months ended March 31, 2018 was $1.20 million (three months ended March 31, 2017 - $1.04 million). At March 31, 2018, there were $0.24 million and $2.35 million of unrecognized compensation costs related to the unvested stock options and RSU awards, respectively. These costs are expected to be recognized over a period of approximately two years.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration